Microbiome Diversity May Predict Survival In Patients With Hematologic Malignancies Who Undergo Allogeneic HCT, Study Indicates
February 27, 2020
MedPage Today (2/26, Swift) reports microbiome diversity “may be prognostic of survival for patients with hematologic malignancies undergoing allogeneic hematopoietic-cell transplantation (HCT),” according to a study published in the New England Journal o...